Michael Eads

Michael Eads is an accomplished pharmaceutical professional with extensive experience in medical sciences and clinical pharmacy. Currently serving as a Principal Medical Scientist at Gilead Sciences since April 2010, Michael has specialized in oncology, COVID-19 treatment with remdesivir, and inflammatory diseases. Prior roles include Associate Director of Medical Sciences focusing on cardiopulmonary diseases, and Senior Medical Scientist at The Medicines Company. Michael's career began in clinical pharmacy, with positions at Rush University Medical Center and various healthcare organizations, contributing to expertise in drug information and education. Academic credentials include a Doctor of Pharmacy (PharmD) from the University of Illinois at Chicago and a Bachelor of Science in Pharmacy from the University of Iowa.